DataMEDS AI, Inc. (MEDS)
NASDAQ: MEDS · Real-Time Price · USD
3.190
-0.090 (-2.74%)
Jul 24, 2026, 2:13 PM EDT - Market open
DataMEDS AI Revenue
DataMEDS AI had revenue of $1.56M in the quarter ending March 31, 2026, a decrease of -85.64%. This brings the company's revenue in the last twelve months to $14.03M, down -51.59% year-over-year. In the year 2025, DataMEDS AI had annual revenue of $23.34M with 28.73% growth.
Revenue (ttm)
$14.03M
Revenue Growth
-51.59%
P/S Ratio
0.57
Revenue / Employee
n/a
Employees
n/a
Market Cap
8.01M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 23.34M | 5.21M | 28.73% |
| Dec 31, 2024 | 18.13M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMEDS News
- 2 days ago - DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets - Accesswire
- 3 days ago - WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC. - PRNewsWire
- 4 days ago - Wellgistics Health Announces Updated Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders - Accesswire
- 8 days ago - Rubenstein Public Relations Named Agency of Record for Wellgistics Health, Inc. - GlobeNewsWire
- 9 days ago - Wellgistics Health Appoints Brett Thompson as Chief Technology Officer - Accesswire
- 24 days ago - Wellgistics Health Executive Chairman and President Exercise Warrants - Accesswire
- 4 weeks ago - DataMeds AI, Inc. Selected as Proposed New Name for Wellgistics Health, Inc. - Accesswire
- 7 weeks ago - Wellgistics Health Provides Mid-Year 2026 Corporate Outlook - Accesswire